Endovascular therapy for long-segment atherosclerotic aortoiliac occlusion

Liangxi Yuan1, Junmin Bao1, Zhiqing Zhao1

  • 1Department of Vascular Surgery, Changhai Hospital, Second Military Medical University, Shanghai, People's Republic of China.

Journal of Vascular Surgery
|November 19, 2013
PubMed

Insights

Endovascular therapy, including stenting and catheter-directed thrombolysis (CDT), is a feasible treatment for long-segment aortoiliac occlusion. This approach demonstrated high technical success and favorable midterm patency with low complication rates.

Area of Science:

  • Vascular Surgery
  • Interventional Cardiology
  • Endovascular Interventions

Background:

  • Long-segment atherosclerotic aortoiliac occlusion poses a significant challenge in vascular treatment.
  • Endovascular therapy offers a less invasive alternative to traditional surgical methods.

Purpose of the Study:

  • To investigate the outcomes of endovascular therapy for long-segment atherosclerotic aortoiliac occlusion.
  • To evaluate the technical success, complication rates, and midterm patency of these interventions.

Main Methods:

  • Retrospective analysis of 20 patients with long-segment aortoiliac occlusion (>10 mm) treated between May 2008 and January 2013.
  • Procedures included stent implantation, with or without catheter-directed thrombolysis (CDT), percutaneous transluminal angioplasty (PTA), and stenting via brachial or femoral artery puncture.

Main Results:

  • Technical success rate was 95% (19 of 20 patients).
  • No in-hospital mortality was observed; one patient experienced retroperitoneal hemorrhage.
  • Significant improvement in postoperative ankle-brachial indexes and clinical Rutherford categories was noted.
  • Primary patency rates were 93.3% at 6 months, 83% at 18 months, and 66.4% at 24 months.

Conclusions:

  • Endovascular therapy is a feasible option for complete long-segment infrarenal aortic occlusion.
  • The combined approach of PTA, stenting, and CDT offers lower complication rates.
  • Favorable midterm patency rates support the use of endovascular interventions in selected patients.
Abstract

Related Concept Videos

Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
478
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
659
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747